Q: Where are you located?
A: Sepracor's corporate headquarters are located at 84 Waterford Drive in Marlborough, Massachusetts, which is approximately 45 minutes west of downtown Boston.

Q: What kinds of drugs do you develop?
A: Sepracor's drug development program and collaboration partnership arrangements have yielded a portfolio of pharmaceutical products and candidates with a focus on the treatment of respiratory and central nervous system disorders. More information about our pharmaceuticals in development can be found in the Products and Pipeline section of this website.

Q: I am a patient and I have a question about your product. Who should I call?
A: Please call our Customer Assistance Center at 1-888-394-7377.

Q: I am a physician and I have a question about your product. Who should I call?
A: Please call our Medical Information Department at 1-800-739-0565.

Q: Where can I find information on participating in a clinical trial?
A: Please call our Customer Assistance Center at 1-888-394-7377.

Q: Who is my local sales representative, or how can I get in touch with a sales representative?
A: Please contact the Customer Assistance Center at 1-888-394-7377.

Q: I am a physician and would like to receive samples of your products. Who should I contact?
A: Please contact the Customer Assistance Center at 1-888-394-7377.

Q:  What are your currently marketed products?
A:   Sepracor Inc. currently markets XOPENEX^® (levalbuterol HCl) Inhalation Solution; XOPENEX HFA^® (levalbuterol tartrate) Inhalation Aerosol, a hydrofluoroalkane (HFA) metered-dose inhaler (MDI); LUNESTA^® (eszopiclone); BROVANA^® (arformoterol tartrate) Inhalation Solution; OMNARIS^® (ciclesonide) Nasal Spray; and ALVESCO^® (ciclesonide) HFA Inhalation Aerosol in the U.S. Sepracor's wholly owned subsidiary, Sepracor Pharmaceuticals, Inc. markets several additional products in Canada that are focused in the cardiovascular, central nervous system, pain and infectious disease therapeutic areas.

Q:  Are any of your marketed products available internationally?
A:  Sepracor's wholly owned subsidiary, Sepracor Pharmaceuticals, Inc. markets several additional products in Canada that are focused in the cardiovascular, central nervous system, pain and infectious disease therapeutic areas.

Q: Can I get free samples of your marketed products without going to my doctor?
A: Our marketed products are available by prescription only. Your doctor, however, may have samples for you.

Q:  Are your marketed products covered under the Medicare drug benefit plan?
A:  XOPENEX Inhalation Solution and BROVANA are covered under Medicare Part B. OMNARIS, LUNESTA, XOPENEX HFA and ALVESCO are covered under Medicare Part D.

Q: I am interested in working for Sepracor. Where do I send my resume?
A: Please visit the Careers section of this web site for information about available positions and contact information.

Q: Who should I contact if I'm a member of the media?
A: If you are a member of the media, please contact the Corporate Communications Department at (508) 481-6700.